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Abstract
Background: Patients with overactive bladder (OAB) are under-diagnosed in the primary care
setting. Primary care physicians (PCP) approach to the patient and appropriate patient disclosure
may contribute to under-diagnosis.
Methods:  An outpatient primary care setting was used to determine the prevalence and
characteristics of OAB. Patients who visited the family medicine outpatient clinic were invited to
answer a self-administered questionnaire. It included questions on evidence of lower urinary tract
symptoms (modified Overactive Bladder-Validated 8-question Screener [OAB-V8]), relevant
medical and surgical history, and demographic data. Relationship between OAB and other
independent variables were analyzed using chi-square and risk ratio (RR) analysis.
Results: Of 325 questionnaires distributed, 311 were returned completed. Patients ranged from
18 to 97 years, the majority women (74.0%) and African American (74.3%). OAB was present in
60.5% of men and 48.3% of women (p = 0.058). OAB was significantly associated with obesity (BMI
> = 30) in women (p = 0.018, RR = 1.72), specifically obese premenopausal women (age < 55 years)
(p = 0.011, RR = 1.98).
Conclusion: OAB prevalence is more than double and higher in men than previously reported.
The relative risk for OAB is significantly greater in obese premenopausal women.
Background
Overactive bladder (OAB) is a common disorder that neg-
atively affects the quality of life [1,2] of our patients and
carries a large socioeconomic burden [3]. OAB is a condi-
tion caused by sudden involuntary contraction (over-
activity) of the bladder detrusor muscles. According to the
International Continence Society (ICS), it is characterized
as urinary urgency, with or without urge incontinence,
usually with frequency and nocturia, in the absence of
causative infection or pathological conditions [4]. On the
basis of a population-based survey of 16 776 men and
women aged 40 years and older conducted by Milsom et
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al [5] in 6 countries, by telephone or direct interview, the
prevalence of OAB in Europe has been estimated to be
15.6 and 17.4% for men and women respectively, with an
overall prevalence of 16.6%. In the NOBLE survey in
which 11740 Americans agreed to participate, overall
prevalence of OAB was 16.9% in women and 16.0% in
men [2].
It is expected that the primary care practitioner (PCP) will
identify and initiate the management of patients with
OAB [6]. Despite its high prevalence, many afflicted
patients remain undiagnosed or untreated [5,7]. The prev-
alence of OAB and its evaluation and management in pri-
mary care has never been studied in the US. Moreover,
little epidemiologic data exists for OAB in ethnic/minority
groups.
Methods
In a two week period, 325 patients aged 16 years and
above who visited one of two family medicine outpatient
centers, for non-urological issues, were invited to answer
a self-administered questionnaire on urinary symptoms
while waiting to be seen by their PCPs; physicians also
completed a survey regarding their experience of patients
with urinary symptoms in their practice (Additional files
1 and 2). 311 patients agreed to fill the questionnaire.
This study was approved by the Institutional Review
Board, SUNY Downstate Medical Center, Brooklyn, NY.
The modified patient questionnaire included 8 questions
on evidence of lower urinary tract symptoms (LUTS)
(Overactive Bladder-Validated 8-question Screener [OAB-
V8]) [8], 2 questions on stress urinary incontinence (SUI),
and one question on incomplete emptying of the bladder
during urination. Responses were answered on a 6-point
Symptom Bother scale ranging from 0 (not at all) to 5 (a
very great deal). An additional question asked about the
effect of urinary symptoms on quality of life (QOL), with
answers ranging from 0 (delighted) to 6 (terrible). The
questionnaire also asked for data on demographic charac-
teristics and relevant medical and surgical history. Patient
weight and height were measured for calculating body
mass index (BMI) (kg/m2).
Patients were considered to have OAB if their OAB-V8
score is ≥ 8 [8]. The presence of specific LUTS was then
analyzed. Patients with OAB were categorized into sub-
types based on their presence of particular symptoms. The
categorization scheme and criteria for LUTS and OAB sub-
types are shown in Table 1. Patients who did not complete
the OAB-V8 and SUI questions were excluded from the
study. For the purpose of our analysis, patients were cate-
gorized into age groups of < 25, 25–34, 35–44, 45–54,
55–64, 65–74, and ≥ 75. Women were considered to be
pre-menopausal if age < 55 years, and postmenopausal if
age ≥ 55.
Unadjusted age- and sex-specific prevalence of OAB and
sex-specific prevalence of LUTS and OAB subtypes were
reported. The chi-square test was used to determine statis-
tically significant differences between the two sexes. To
determine the relationship between OAB prevalence and
other factors (race, menopausal status, BMI, history of
smoking and history of hysterectomy), covariates were
first individually evaluated using the chi-square test. Sta-
tistically significant (p < .05) covariates were retained for
risk ratio analysis. Patients were excluded from a specific
analysis if they did not report on the variable to be ana-
lyzed. Results are presented as risk ratio and 95% confi-
dence interval (RR, 95% CI).
Table 1: Criteria for LUTS and OAB subtypes
Idenitifcation criteria
LUTS
Urgency Answer ≥1 to any one of the three OAB-V8 questions on urge to urinate
Frequency Answer ≥1 to any one of the two OAB-V8 questions on frequent urination
Nocturia Answer ≥1 to the OAB-V8 question on nocturia
Urge urinary incontinence (UUI) Answer ≥1 to one of the two OAB-V8 questions on urine leakage associated with urge
Stress urinary incontinence (SUI) Answer ≥1 to one of the two questions on urine leakage associated with physical activities, 
sneezing, coughing, or laughing
Mixed urinary incontinence (MUI) Meet the criteria for both UUI and SUI described above
Incomplete emptying Answer ≥1 to the question on incomplete emptying
OAB subtypes (based on presence of above symptoms)
OAB with frequency alone (OAB-F) OAB-V8 score ≥8 with symptoms of frequency and/or nocturia only
OAB with urgency without incontinence (OAB-U) OAB-V8 score ≥8 with symptoms of urgency without incontinence
OAB with urge urinary incontinence (OAB-UUI) OAB-V8 score ≥8 with symptoms of UUI and no SUI
OAB with stress urinary incontinence (OAB-SUI) OAB-V8 score ≥8 with symptoms of SUI and no UUI
OAB with mixed urinary incontinence (OAB-MUI) OAB-V8 score ≥8 with symptoms of MUI
LUTS = Lower urinary tract symptomsBMC Family Practice 2009, 10:8 http://www.biomedcentral.com/1471-2296/10/8
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All statistical analyses were performed using SPSS 15.0 for
Windows.
Results
Table 2 reports the characteristics of patients studied
including age, sex, ethnicity, education, BMI, smoking,
prior surgical history and OAB status. Patients ranged
from 18 to 97 years, the majority were women (74.0%)
and Black (74.3%). Of the 219 women who reported their
age, 49.3% were postmenopausal. OAB was present in
60.5% men and 48.3% women (p > .05). Prevalence of
OAB increased with age in men but did not vary with age
in women.
Analysis of the 151 patients without OAB (119 women,
32 men) shows that women reported 53.8% frequency
and 44.5% nocturia. Urgency was present in 25.2% of the
119 women, with UUI in 23.3% of these women. SUI was
present in 25.2% of the 119 women. Among the men
without OAB there were less reported lower urinary tract
symptoms (31.3% frequency, 46.9% nocturia and 12.5%
urgency).
Table 3 identifies the prevalence of LUTS and OAB sub-
types in men and women with OAB. Each of the three
OAB-defining symptoms, urgency, frequency, and noctu-
ria, were present in almost 90% of OAB patients. UUI was
highly prevalent in both genders, however more so in
women (79.3% vs 75.5%, p > .05). SUI was significantly
more prevalent in women (60.4% vs 36.7%, p = .006).
Incomplete emptying, a symptom often accompanying
OAB, was present in about half OAB patients and was sim-
ilar in both men and women (53.1% vs 47.7%).
The sex-specific differences in OAB subtypes found in this
study reveal that the OAB-MUI subtype was significantly
Table 2: Characteristics of participants
Characteristic, n (%) Male (n = 81) Female (n = 230) Total (N = 311)
Age, years
< 25 2 (2.5) 14 (6.1) 16 (5.1)
25–34 5 (6.2) 27 (11.7) 32 (10.3)
35–44 9 (11.1) 28 (12.2) 37 (11.9)
45–54 20 (24.7) 42 (18.3) 62 (19.9)
55–64 16 (19.8) 41 (17.8) 57 (18.3)
65–74 20 (24.7) 42 (18.3) 62 (19.9)
≥75 8 (9.9) 25 (10.9) 33 (10.6)
Unknown 1 (1.2) 11 (4.8) 12 (3.9)
Race
Black 57 (70.4) 174 (75.7) 231 (74.3)
Hispanic 13 (16.1) 27 (11.7) 40 (12.9)
White 0 (0.0) 3 (1.3) 3 (0.01)
Other/Not stated 11 (13.6) 26 (11.3) 37 (11.9)
Education
Less than high school 8 (9.9) 13 (5.7) 21 (6.8)
High school graduate 24 (29.6) 72 (31.3) 96 (30.9)
Some college/college graduate 19 (23.5) 47 (20.4) 66 (21.2)
Graduate school 4 (4.9) 13 (5.7) 17 (5.5)
Not stated 26 (32.1) 85 (37.0) 111 (35.7)
Body mass index (BMI), kg/m2
< 25.0 12 (14.8) 38 (16.5) 50 (16.1)
25.0–29.9 27 (33.3) 79 (34.3) 106 (34.1)
≥30 31 (38.3) 96 (41.7) 127 (40.8)
Not stated 11 (13.6) 17 (7.4) 28 (9.0)
History of smoking*
Yes 36 (44.4) 59 (25.7) 95 (30.5)
No 45 (55.6) 171 (74.3) 216 (69.5)
Previous surgical history
Bladder surgery** 0 (0.0) 8 (3.5) 8 (2.6)
Urinary leakage surgery** 0 (0.0) 1 (0.4) 1 (0.3)
Hysterectomy*** -- -- 49 (21.3) -- --
Prostate surgery 5 (6.2) -- -- -- --
OAB status
Normal 32 (39.5) 119 (51.7) 151 (48.5)
OAB with UI 37 (45.7) 92 (40.0) 129 (41.5)
OAB without UI 12 (14.8) 19 (8.3) 31 (10.0)BMC Family Practice 2009, 10:8 http://www.biomedcentral.com/1471-2296/10/8
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more common in women (56.8% women vs 34.7% men,
p = .010) and OAB-UUI was significantly more common
in men (40.8% vs 22.5%, p = .018). OAB-U was also more
prevalent in men, and men were less likely to have OAB
with incontinence than women (p > .05).
Age- and sex-specific prevalence of OAB and OAB sub-
types are shown in Figure 1. Prevalence of OAB increased
with age in men but not in women (Figure 1A). Preva-
lence of OAB-U increases steadily after age 30 in both gen-
ders and peaks at age 60 for women and at age 70 for men
(Figure 1B). For OAB-UUI, the prevalence in men
increases from 0% at age 20 to a peak of 16.3% by age 50
(Figure 1C). OAB-UUI prevalence in women is lower than
men in all age groups except those women younger than
40. For OAB-MUI, the prevalence is higher in women at
most ages (Figure 1D).
Unexpectedly, OAB was present in 53.2% pre-menopau-
sal women and 44.4% postmenopausal women (Table 4).
Premenopausal women have a higher prevalence of OAB-
MUI (64.4% vs 52.1%, p > .05) than post-menopausal
women with OAB. Postmenopausal women have a higher
prevalence of OAB-U (18.8% vs 10.2%, p > .05) and OAB-
UUI (25.0% vs 15.3%, p > .05).
OAB was significantly associated with obesity (BMI ≥ 30)
in women (p = .018) (Table 5). However when meno-
pause status was controlled, such association was only
found in obesity pre-menopausal women (p = .013), who
had a 2-fold increased risk for OAB (RR = 1.98, 1.05–
3.74). Overall, the risk for obese women to have OAB is
1.72 times (95% CI 1.04–2.84) that of women with nor-
mal weight. OAB is significantly associated with incom-
plete bladder emptying (p < .001) and with SUI (p < .001)
in both men and women. OAB was not shown to vary
with race, cigarette use, history of hysterectomy, meno-
pause status in women or BMI in men (p > .05).
Discussion
In this study we investigated the prevalence of OAB, its
evaluation in primary care using a patient questionnaire.
We found an OAB prevalence that is more than double
that reported in a recent US population-based study [2], a
finding not previously reported [2,5,7]. Variations from
earlier studies may be attributed to the methodology of
data collection and our non-traditional minority, pre-
dominantly female target population. This study used a
clinically validated questionnaire [8] with added ques-
tions focusing on stress urinary incontinence to identify
OAB patients in primary care. Unlike two population-
based studies [2,7] in which responses regarding LUTS
were elicited from non-institutionalized individuals
through telephone interviews, our questionnaire relies on
self-report by primary care physicians and outpatients. In
this sense, our data collection method resembles one
office-based PCP study [7], which had an OAB prevalence
estimate that was high (26.5%) and most nearly resem-
bles our results. In all three previous studies cited above,
OAB was defined based on the presence and/or frequency
of specific LUTS, and the study populations were predom-
inately white. Our study differs in that the OAB criteria are
based on scoring on a symptom bother scale and the
patient population is predominately black. These differ-
ences may explain in part the discrepancy in OAB preva-
lence observed in the current study compared to those
previously reported in the literature.
Significantly more men compared to women with OAB
have OAB-UUI in this study. In addition, OAB with incon-
tinence is more common than OAB without incontinence
in our study in both men and women. These results are in
sharp contrast to data reported previously [2], which
showed women to be more likely to have OAB-UUI, and
men to be more likely to have OAB without incontinence.
However, when UUI is taken as a symptom, the higher
prevalence we found of UUI and SUI in women than in
men are consistent with other studies [2,7]. Most studies
on female UI have reported SUI as more common than
UUI,[7] especially in younger women,[9,10] while MUI
was the major presentation overall [7,9,10]. We find that
most women who have OAB have OAB-MUI. However,
UUI and OAB-UUI are more prevalent than SUI and OAB-
SUI in women with OAB in our study. This finding is sup-
ported by others [11,12] who reported black women to
have lower rates of SUI but higher rates of UUI than white
women. The significant association between OAB and SUI
we found is also supported [10]. While most studies have
Table 3: Prevalence of LUTS and OAB subtypes by gender
n (%) Male (n = 49) Female (n = 111) p value
Symptoms
Urgency 44 (89.8) 100 (90.1) .954
Frequency 48 (98.0) 110 (99.1) .550
Nocturia 41 (83.7) 101 (91.0) .177
UUI 37 (75.5) 88 (79.3) .595
SUI 18 (36.7) 67 (60.4) .006
Incomplete emptying 26 (53.1) 53 (47.7) .535
OAB subtypes
OAB-F 1 (2.0) 4 (3.6) .600
OAB-U 11 (22.4) 15 (13.5) .158
OAB-UUI 20 (40.8) 25 (22.5) .018
OAB-SUI 0 (0.0) 4 (3.6) .178
OAB-MUI 17 (34.7) 63 (56.8) .010
OAB with incontinence 37 (75.5) 92 (82.9) .277
UUI = urge urinary incontinence, SUI = stress urinary incontinence, 
OAB-F = OAB with frequency alone,
OAB-U = OAB with urgency without incontinence, OAB-UUI = OAB 
with urge urinary incontinence,
OAB-SUI = OAB with stress urinary incontinence, OAB-MUI = OAB 
with mixed urinary incontinenceBMC Family Practice 2009, 10:8 http://www.biomedcentral.com/1471-2296/10/8
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reported white women to have higher risk for UI in gen-
eral [9,13,14], how this would affect the characterization
of OAB prevalence in such population could be the focus
of future investigation.
As in earlier reports [2,5,7], we find OAB prevalence to
increase with advancing age, however this relationship is
observed only in men and we do not understand why this
association is not found in women. We also find a signif-
icant association between OAB and incomplete emptying
of the bladder in both men and women. Bladder outlet
obstruction leading to incomplete emptying is commonly
seen in benign prostate hyperplasia (BPH) in older men.
Studies have reported that OAB often coexists with BPH
[15], and the associated incomplete emptying of the blad-
der as a cause of OAB has been discussed in the clinical
scenario of BPH [16]. However, the relation between OAB
and incomplete emptying in women may involve mecha-
nisms other than obstruction [16].
Obesity as a risk factor for OAB [2,10] and UI [9,14,17]
has been previously reported. The risk for OAB we found
for premenopausal obese women (1.98) is similar to that
reported by Stewart et al [2] (2.2) in obese women with
OAB-UUI. In concordance with results reported by Stew-
art et al, we do not find an association between OAB and
obesity in men or in the general population studied. There
has been no report of the relationship between smoking
Prevalence of OAB subtypes by age and sex Figure 1
Prevalence of OAB subtypes by age and sex. Data represent percent (%) prevalence of male and female patients by age 
for (A) all subtypes, (B) OAB-U, (C) OAB-UUI, (D) OAB – MUI. OAB-U = OAB with urgency without incontinence, OAB-UUI 
= OAB with urge urinary incontinence, OAB-MUI = OAB with mixed urinary incontinence.
0
20
40
60
80
10 0
<25 25-34 35-44 45-54 55-64 65-74 75
Age (years)
Male
Female
0
2
4
6
8
10
12
14
16
<25 25-34 35-44 45-54 55-64 65-74 75
Age (years)
Male
Female
0
2
4
6
8
10
12
14
16
<25 25-34 35-44 45-54 55-64 65-74 75
Age (years)
Male
Female
0
2
4
6
8
10
12
14
16
<25 25-34 35-44 45-54 55-64 65-74 75
Age (years)
Male
Female
A: 	

	p B: p
C: p D: p
P
r
e
v
a
l
e
n
c
e
 
(
%
)
P
r
e
v
a
l
e
n
c
e
 
(
%
)
P
r
e
v
a
l
e
n
c
e
 
(
%
)
P
r
e
v
a
l
e
n
c
e
 
(
%
)BMC Family Practice 2009, 10:8 http://www.biomedcentral.com/1471-2296/10/8
Page 6 of 7
(page number not for citation purposes)
and OAB, and smoking is shown as a risk factor for UI in
some studies [14,17] but not others [9]. We do not find
any significant association for OAB and smoking in men
or women.
Previous studies have demonstrated that hysterectomy
increased the risk for UUI [18] but not SUI [18,19]. Hys-
terectomy is thought to contribute to UI through pelvic
nerves or pelvic floor damage. Its relationship and contri-
bution to OAB has not been studied, and we do not find
any significant association between OAB and hysterec-
tomy in pre- or postmenopausal women.
A number of limitations should be considered when inter-
preting the results of this study. Language barriers and cul-
tural differences in how comfortable patients would
voluntarily answer particular questions are challenges in
implementing a questionnaire-based study. Measures
have been taken to ensure that questionnaires were dis-
tributed to all qualified patients who visited the clinic,
with the intention to minimize overestimation of preva-
lence. In our present study the response rate was 95%. The
majority of our OAB patients have all 3 cardinal symp-
toms (frequency, nocturia, and urgency/UUI), suggesting
that they have OAB and should be evaluated and man-
aged as such.
Conclusion
The high prevalence of OAB found in this study suggests
that the needs of many of our patients with OAB may not
be met by their primary care providers. Increasing the
awareness and knowledge of OAB among PCPs and
adopting effective clinical approaches such as a reliable,
valid and "user-friendly" screening questionnaire may
serve to both allow patients with urinary symptoms to
comfortably report their bladder related complaints and
increase the ability of PCP's to recognize, evaluate and
treat OAB. Future studies should focus on differentiating
OAB patients across various ethnic groups and in diverse
clinic settings. Identifying culturally sensitive strategies for
evaluating and managing primary care patients with OAB
may help to decrease the burden of OAB and better serve
our patients.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
Patient and data recruitment (WC, NK, KC, MV). Manu-
script preparation (WC, NK, KC, MB, MV). Data and sta-
tistical analysis (WC, NK, KC, MB, MV). All authors read
and approved the final manuscript.
Additional material
Additional file 1
Physician Survey.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2296-10-8-S1.doc]
Table 4: Prevalence of LUTS and OAB subtypes by menopausal status
n (%) Premenopause (n = 111) Postmenopause (n = 108) p value
OAB positive 59 (53.2) 48 (44.4) .197
OAB subtypes
OAB-F 2 (3.4) 2 (4.2) .833
OAB-U 6 (10.2) 9 (18.8) .204
OAB-UUI 9 (15.3) 12 (25.0) .207
OAB-SUI 4 (6.8) 0 (0) .066
OAB-MUI 38 (64.4) 25 (52.1) .198
OAB with incontinence 51 (86.4) 37 (77.1) .208
OAB-F = OAB with frequency alone, OAB-U = OAB with urgency without incontinence,
OAB-UUI = OAB with urge urinary incontinence, OAB-SUI = OAB with stress urinary incontinence,
OAB-MUI = OAB with mixed urinary incontinence
Table 5: Relative risk for OAB by BMI category
Risk Ratio (RR)**
Comparison group* RR 95% CI p
All women
BMI 25.0–29.9 --- --- .091
BMI ≥30.0 1.72 1.04 – 2.84 .018
Premenopausal women
BMI 25.0–29.9 --- --- .394
BMI ≥30.0 1.98 1.05 – 3.74 .011
Postmenopausal women
BMI 25.0–29.9 --- --- .072
BMI ≥30.0 --- --- .188
*Women in the corresponding age group with BMI < 25 served as the 
reference group
** Risk ratio was calculated only when p < .05;
Risk ratio = prevalence of OAB in women with comparison BMI/
prevalence of OAB in women with reference BMI of < 25Publish with BioMed Central    and   every 
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